Atara Biotherapeutics

About Atara Biotherapeutics

Atara Biotherapeutics is an allogeneic T-cell immunotherapy company focused on harnessing the natural biology of T cells to develop transformative therapies for patients with cancer and autoimmune conditions. Their mission is to create off-the-shelf therapies that can be rapidly delivered to patients.

Products & Services

Allogeneic T-cell Therapies:Off-the-shelf therapies designed for rapid delivery within days to treat cancer and autoimmune conditions.

ATA3219:An investigational therapy targeting B-Cell Non-Hodgkin Lymphoma and Systemic Lupus Erythematosus/Lupus Nephritis (SLE/LN).

ATA3431:An investigational T-cell therapy in the company's pipeline for undisclosed specific indications.

EBVALLO™ (tabelecleucel):A therapy with regulatory updates provided, part of Atara's offerings for specific conditions.

Specialties

Allogeneic T-cell Immunotherapy Cancer Treatment Autoimmune Conditions Scalable Manufacturing CAR T Technology

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Registered Direct Offering T: - FT: Registered Direct Offering	A: 16000000 MR: - FA: $16 million FAN: 16000000	D: 2025-05-15 FD: 2025-05-15	4 investors
2	RT: Registered Direct Offering T: - FT: Registered Direct Offering	A: 36000000 MR: - FA: $36 million FAN: 36000000	D: 2024-09-03 FD: 2024-09-03	4 investors
3	RT: Registered Direct Offering T: - FT: Registered Direct Offering	A: 15000000 MR: - FA: 15 million FAN: 15000000	D: 2024-01-08 FD: 2024-01-08	1 investors

Registered Direct Offering Latest

2025-05-15

$16.0M

4 investors (Pro only)

Registered Direct Offering 2024-09-03

$36.0M

Registered Direct Offering 2024-01-08

$15.0M

View 2 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

O

Ola

Heart and kidney transplant recipient, PTLD advocate

C

Cokey Nguyen

President and Chief Executive Officer

Y

Yanina Grant-Huerta

Chief Accounting Officer

J

Jim Sesic

Senior Vice President, Regulatory Affairs

J

John Chao

Head of Legal

P

Pascal Touchon

Chairman of the Board

View 14 more team members with Pro

Unlock Full Team Directory

Recent News